CHICAGO -- A mutation-agnostic gene therapy for retinitis pigmentosa (RP) showed promise for improving vision in severely ...

PYC Therapeutics Limited (AU:PYC) has released an update. PYC Therapeutics has announced positive results from its ongoing clinical trials for ...

Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for retinal degenerative ...

PYC Therapeutics Limited (AU:PYC) has released an update. PYC Therapeutics has received Orphan Drug Designation from the US FDA for its ...

Up to half of patients showed significant improvement in study results presented at the American Academy of Ophthalmology ...

Patients with substantial vision loss due to advanced retinitis pigmentosa (RP) achieved meaningfully improved visual acuity ...

In data presented at the 128th annual meeting of the American Academy of Ophthalmology in Chicago, the two-year study finds ...

Comedian Chris McCausland has again wowed the Strictly Come Dancing judges and moved viewers at home to tears with a Waltz ...

Researchers have identified new drug targets for therapies that could benefit patients with different forms of retinitis ...

An international team of researchers has identified new drug targets for therapies that could benefit patients with different forms of retinitis pigmentosa and other inherited retinal diseases.

Exciting results for MeiraGTx Holdings plc's GAD gene therapy for Parkinson's Disease, with promising phase 1/2 data and ...